Patent US5032592A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5032592A Expired / Lapsed US ⏱️ 0.0 years remaining

Alkene, alkyne or cycloalkylene derivatives

Assignee: AstraZeneca UK Ltd
•
Filing: 1989-05-30
•
Granted: 1991-07-16
•
Expires: 2009-05-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula ##STR1## wherein X has the formula ##STR2## wherein ring a is phenyl, naphthyl or heterocyclic; wherein R 1 is hydrogen, alkyl, alkanoyl or aroyl; wherein R 2 , R 3 and R 4 , which may be the same or different, each is an electron withdrawing substituent selected from halogeno, nitro, cyano, trifluoromethyl, alkylthio, alkylsulphinyl, and alkylsulphonyl or each is hydrogen, alkyl, alkoxy or dialkylamino provided that when ring A is phenyl or naphthyl at least one of R 2 , R 3 and R 4 is an electron-withdrawing substituent; wherein R 5 and R 6 , which may be the same or different, each is hydrogen, halogeno or alkyl; wherein R 7 is alkyl or halogenoalkyl; and wherein R 8 is carbamoyl, alkyl, cycloalkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalkenyl, halogenoalkynyl, alkanoyl, alkylcarbamoyl, dialkylcarbamoyl or aroyl; or wherein R 8 is alkyl or alkenyl which bears one or more substituents selected from cyano, carbamoyl, amino, hydroxy, alkanoyl, alkoxy, alkylthio, alkenylthio, alkylsulphinyl, alkenylsulphinyl, alkylsulphonyl, alkenylsulphonyl, alkanoylamino, alkoxycarbonylamino, alkylsulphonamido, alkylamino, dialkylamino, dialkylsulphamoyl, aroyl, aryl, arylthio, arylsulphinyl, arylsulphonyl, heterocyclylthio, heterocyclylsulphinyl and heterocyclylsulphonyl; or wherein R 8 has the formula ##STR3## wherein ring B is phenyl, naphthyl or heterocyclyl and wherein R 2 , R 3 and R 4 have any of the meanings stated above, provided that when R 7 is methyl R 8 is not also methyl.

Inventors

  • 👤 Leslie R. Hughes
  • 👤 John Oldfield
  • 👤 Howard Tucker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 11:32
CPC Classifications
C; C07; C07C; C07C17/00; C07C17/23; A; A61; A61P; A61P17/00; C07C17/26; C07C17/272; C07C17/278; C07C205/00; C07C205/13; C07C205/26; C07C205/45; C07C255/00; C07C317/00; C07C323/00; C07C33/00; C07C33/40; C07C33/46; C07C33/48; C07C33/483; C07C33/50; C07C45/00; C07C45/26; C07C45/51; C07C45/54; C07C45/61; C07C45/67; C07C45/68; C07C45/72; C07C45/74; C07C47/00; C07C47/20; C07C47/26; C07C47/273; C07C49/00; C07C49/20; C07C49/227; C07C49/233; C07C49/235; C07C49/24; C07C49/245; C07C49/248; C07C59/00; C07C59/40; C07C59/42; C07C59/56; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/32; C07D213/34; C07D213/54; C07D213/57; C07D213/60; C07D213/61; C07D213/62; C07D213/70; C07D213/71; C07D215/00; C07D215/02; C07D215/12; C07D215/14; C07D215/16; C07D215/36; C07D219/00; C07D219/04; C07D233/00; C07D233/54; C07D233/66; C07D233/84; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/32; C07D239/38; C07D239/46; C07D239/47; C07D239/56; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/12; C07D251/00; C07D251/02; C07D251/12; C07D251/26; C07D251/38; C07D277/00; C07D277/02; C07D277/20; C07D277/22; C07D277/24; C07D277/32; C07D277/36; C07D303/00; C07D303/02; C07D303/08; C07D333/00; C07D333/02; C07D333/04; C07D333/26; C07D333/28; C07D333/38; C07D333/42; C07D333/44; C07D339/00; C07D339/02; C07D339/06; C07D473/00; C07D473/02; C07D473/24; C07D473/26; C07D473/36; C07D473/38; C07D487/00; C07D487/02; C07D487/04; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/0803; C07F7/081

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 405 words
A compound of the formula ##STR29## wherein X has the formula ##STR30## wherein ring A is phenyl, naphthyl, pyridyl, quinolyl or thienyl; wherein R 1 is hydrogen, alkanoyl of up to 6 carbon atoms or aroyl of up to 10 carbon atoms; wherein R 2 , R 3 and R 4 , which may be the same of different, each is an electron withdrawing substituent selected from halogeno, nitro, cyano and trifluoromethyl, and alkylthio, alkylsulphinyl and alkylsulphonyl each of up to 6 carbon atoms, or each is hydrogen or alkyl, alkoxy or dialkylamino each of up to 6 carbon atoms, provided that when ring A is phenyl or naphthyl at least one of R 2 , R 3 and R 4 is an electron-withdrawing substituent; wherein R 5 and R 6 , which may be the same or different, each is hydrogen, halogeno or alkyl of up to 6 carbon atoms; wherein R 7 is halogenoalkyl of up to 6 carbon atoms; and wherein R 8 is carbamoyl, alkyl, cycloalkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalkenyl, halogenoalkynyl or alkanoyl each of up to 6 carbon atoms, or alkylcarbamoyl or dialkylcarbamoyl wherein each alkyl is of up to 6 carbon atoms, or aroyl of up to 10 carbon atoms; or wherein R 8 is alkyl or alkenyl each of up to 6 carbon atoms which bears one or more substituents selected from cyano, carbamoyl, amino and hydroxy, alkanoyl, alkoxy, alkylthio, alkenylthio, alkylsulphinyl, alkenylsulphinyl, alkylsulphonyl, alkenylsulphonyl, alkanoylamino, alkoxycarbonylamino and alkylsulphonamido each of up to 6 carbon atoms, alkylamino, dialkylamino and dialkylsulphamoyl wherein each alkyl is of up to 6 carbon atoms, aroyl, aryl, arylthio, arylsulphinyl and arylsulphonyl each of up to 10 carbon atoms and heterocyclylthio, heterocyclylsulphinyl and heterocyclylsulphonyl and wherein the heterocyclyl group in R 8 is a 5- or 6-membered saturated or unsaturated heterocyclic which contains one, two or three hetero atoms selected from oxygen, nitrogen and sulphur, which heterocyclic is a single ring or is fused to one or two benzo-rings or to another heterocyclic ring as defined above, and which heterocyclic is unsubstituted or bears substituents R 2 , R 3 and R 4 as defined above, or may also bear one or more hydroxy, mercapto or amino substituents; or wherein R 8 has the formula ##STR31## wherein ring B is phenyl or naphthyl or ring B is pyridyl or thiazolyl which is unsubstituted or bears a halogeno or trifluoromethyl substituent, or is unsubstituted 1,3-dithian-2-yl.
Claim 2
Dependent Claim 405 words
A compound of the formula ##STR29## wherein X has the formula ##STR30## wherein ring A is phenyl, naphthyl, pyridyl, quinolyl or thienyl; wherein R 1 is hydrogen, alkanoyl of up to 6 carbon atoms or aroyl of up to 10 carbon atoms; wherein R 2 , R 3 and R 4 , which may be the same of different, each is an electron withdrawing substituent selected from halogeno, nitro, cyano and trifluoromethyl, and alkylthio, alkylsulphinyl and alkylsulphonyl each of up to 6 carbon atoms, or each is hydrogen or alkyl, alkoxy or dialkylamino each of up to 6 carbon atoms, provided that when ring A is phenyl or naphthyl at least one of R 2 , R 3 and R 4 is an electron-withdrawing substituent; wherein R 5 and R 6 , which may be the same or different, each is hydrogen, halogeno or alkyl of up to 6 carbon atoms; wherein R 7 is halogenoalkyl of up to 6 carbon atoms; and wherein R 8 is carbamoyl, alkyl, cycloalkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalkenyl, halogenoalkynyl or alkanoyl each of up to 6 carbon atoms, or alkylcarbamoyl or dialkylcarbamoyl wherein each alkyl is of up to 6 carbon atoms, or aroyl of up to 10 carbon atoms; or wherein R 8 is alkyl or alkenyl each of up to 6 carbon atoms which bears one or more substituents selected from cyano, carbamoyl, amino and hydroxy, alkanoyl, alkoxy, alkylthio, alkenylthio, alkylsulphinyl, alkenylsulphinyl, alkylsulphonyl, alkenylsulphonyl, alkanoylamino, alkoxycarbonylamino and alkylsulphonamido each of up to 6 carbon atoms, alkylamino, dialkylamino and dialkylsulphamoyl wherein each alkyl is of up to 6 carbon atoms, aroyl, aryl, arylthio, arylsulphinyl and arylsulphonyl each of up to 10 carbon atoms and heterocyclylthio, heterocyclylsulphinyl and heterocyclylsulphonyl and wherein the heterocyclyl group in R 8 is a 5- or 6-membered saturated or unsaturated heterocyclic which contains one, two or three hetero atoms selected from oxygen, nitrogen and sulphur, which heterocyclic is a single ring or is fused to one or two benzo-rings or to another heterocyclic ring as defined above, and which heterocyclic is unsubstituted or bears substituents R 2 , R 3 and R 4 as defined above, or may also bear one or more hydroxy, mercapto or amino substituents; or wherein R 8 has the formula ##STR31## wherein ring B is phenyl or naphthyl or ring B is pyridyl or thiazolyl which is unsubstituted or bears a halogeno or trifluoromethyl substituent, or is unsubstituted 1,3-dithian-2-yl.
Claim 3
Dependent Claim 184 words
A compound of the formula stated in claim 1 wherein X is --CR 5 ═CR 6 --, wherein ring A is phenyl, wherein one or two (the same or different) of R 2 , R 3 and R 4 are fluoro, chloro, cyano, trifluoromethyl or nitro, the others of R 2 , R 3 and R 4 being hydrogen, wherein R 1 , R 5 and R 6 are all hydrogen, wherein R 7 is trifluoromethyl, pentafluoroethyl, heptafluoropropyl, chloromethyl or dichloromethyl, wherein R 8 is methyl, ethyl, n-propyl, isopropyl, n-butyl, cyclopropyl, cyclopentyl, trifluoromethyl, chloromethyl, dichloromethyl, ethynyl, chloroethynyl, acetyl or propionyl or is methylene (13 CH 2 --) substituted by cyano, hydroxy, carbamoyl, formyl, acetyl, alkylthio, alkenylthio, alkylsulphonyl or alkenylsulphonyl each of up to 6 carbon atoms, phenylthio or phenylsulphonyl which itself is unsubstituted or bears a fluoro, chloro, nitro, carbamoyl, acetamido, methylthio or methylsulphonyl substituent, pyridyl, quinolyl, pyrimidinyl, purinyl, pyrazolopyrimidinyl, thiazolyl, imidazolyl or triazolyl any of which is unsubstituted or bears a hydroxy, mercapto, amino, chloro, trifluoromethyl or methyl substituent, and wherein the --CR 5 ═CR 6 -- group is in the trans- configuration.
Claim 4
Dependent Claim 24 words
A -pharmaceutical or veterinary composition having antiandrogenic properties which comprises a compound claimed in claim 1 in association with a pharmaceutically-acceptable diluent or carrier.
Claim 5
Dependent Claim 61 words
A composition as claimed in claim 3 which is in a form suitable for oral dosage, as a tablet, capsule, aqueous or oily solution or suspension, or emulsion, or in the form of a sterile solution or suspension suitable for parenteral administration, or in the form of an ointment or lotion for topical administration, or in the form of a suppository.
Claim 6
Dependent Claim 27 words
A method for producing an antiandrogenic effect in a warm-blooded animal which comprises administering to said animal an effective amount of a compound claimed in claim 1.

References Cited (Backward Citations)

US3979471A Cited
JPS52128329A Cited
US4282218A Cited
US4191775A Cited
US4139561A Cited
US4329776A Cited
US4532341A Cited
US4386080A Cited
US4507140A Cited
EP0193303A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-15 1995-01-14 1995-07-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-15 1999-01-14 1999-07-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-15 2003-01-14 2003-07-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag